Skip to content
healthcare.dev

METHYLPHENIDATE HYDROCHLORIDE

NDC 75834-324, METHYLPHENIDATE HYDROCHLORIDE, tablet, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-324
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208737
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-324 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
75834-324-0175834032401100 TABLET in 1 BOTTLE (75834-324-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4cc16009-44ad-4055-ac76-efa282f1ff47
  • NADAC price for package 75834032401

    GET /v1/drugs/nadac/75834032401

Use it

Look up 75834-324 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-324 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-324. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.